Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF with Chemoimmunotherapy in Low-Grade NHL
NCT00208975Phase 2Terminated
- Sponsor
- Emory University
- Start
- Jul 2002
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in non-Hodgkin lymphoma (NHL), sponsored by Emory University. Started Jul 2002; status: terminated.
02
Drugs
sargramostim
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00208975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208975.